false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - The Car ...
Using Equations to Guide Kidney and Cardiovascular ...
Using Equations to Guide Kidney and Cardiovascular Care: A Case-Based Discussion of Risk Predication in CKM
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker argues that obesity, diabetes, chronic kidney disease (CKD), and cardiovascular disease should be managed as interconnected conditions. Clinicians should assess a patient’s cardiovascular-kidney-metabolic (CKM) stage and use absolute-risk equations to guide treatment. PREVENT estimates 10- and 30-year cardiovascular risk, while the Kidney Failure Risk Equation (KFRE) estimates two- and five-year kidney-failure risk. Together, these tools provide finer risk assessment than staging alone and are available in Epic.<br /><br />Albuminuria and reduced GFR predict a range of cardiovascular and kidney outcomes, yet urine albumin testing remains underused. Risk assessment can help prioritize therapies with benefits across organ systems, including blood-pressure treatment, statins, SGLT2 inhibitors, GLP-1 therapies, and finerenone, alongside lifestyle and weight management. The speaker emphasizes treating high-risk patients promptly, improving statin use in CKD, and not leaving cardiovascular prevention solely to cardiologists. Key actions: think CKM, measure UACR, quantify risk, and coordinate multi-organ care.
Asset Caption
Morgan Grams, MD, PhD
Meta Tag
Speaker
Morgan Grams
Keywords
cardiovascular-kidney-metabolic syndrome
obesity
diabetes
chronic kidney disease
absolute risk assessment
albuminuria
×
Please select your language
1
English